Pap testing and sexual activity among young women in the united states

Obstetrics and Gynecology

Volumn 114, Issue 6, 2009, Pages 1213-1219

  Saraiya, Mona ^b   Martinez, Gladys ^b   Glaser, Katherine ^a   Kulasingam, Shalini ^b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER SCREENING; ETHNIC DIFFERENCE; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HUMAN; JUVENILE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRACTICE GUIDELINE; PRIORITY JOURNAL; SELF REPORT; SEXUAL BEHAVIOR; UNITED STATES; UTERINE CERVIX CANCER; AGE; COITUS; NATIONAL HEALTH ORGANIZATION; STATISTICS; VAGINA SMEAR;

ADOLESCENT; AGE FACTORS; COITUS; FEMALE; HUMANS; NATIONAL CENTER FOR HEALTH STATISTICS (U.S.); UNITED STATES; VAGINAL SMEARS; YOUNG ADULT;

EID: 73349089045     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181be3db4     Document Type: Article

References (28)

1. US Preventive Services Task Force. Screening for cervical cancer. In: Guide to clinical preventive services. Williams and Wilkins: Baltimore (MD); 1996. p. 105-118
2. American College of Obstetricians and Gynecologists. Routine cancer screening. ACOG Committee Opinion 185. Washington, DC: ACOG; 1999.
3. Smith RA, Mettlin CJ, Davis KJ, Eyre H. American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin 2000;50:34-49.
4. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002;52:342-362 (Pubitemid 35446606)
5. Cervical cytology screening. ACOG Practice Bulletin No. 45. American College of Obstetricians and Gynecologists. Obstet Gynecol 2003;102:417-427
6. U.S. Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Rockville (MD): Agency for Healthcare Research and Quality; 2003. Report No.: AHRQ Publication No. 03-515A.
7. Centers for Disease Control and Prevention National Center for Health Statistics. National survey of family growth 2002. Available at: http://www.cdc.gov/nchs/data/nsfg/ UserGuide-2002NSFG.pdf. Accessed April 22, 2008.
8. Chandra A, Martinez GM, Mosher WD, Abma JC, Jones J. Fertility, family planning, and reproductive health of U.S. women: data from the 2002 National Survey of Family Growth. Vital Health Stat 23 2005:1-160.
9. Bray F, Carstensen B, Møller H, Zappa M, Zakelj MP, Lawrence G, et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomark-ers Prev 2005;14:2191-2199
10. Watson M, Saraiya M, Benard V, Coughlin SS, Flowers L, Cokkinides V, et al. Burden of cervical cancer in the United States, 1998-2003. Cancer. 2008;113:2855-2864
11. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-819
12. Waxman AG. Guidelines for cervical cancer screening: history and scientific rationale. Clin Obstet Gynecol 2005;48:77-97.
13. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D, et al 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ [published erratum appears in J Low Genit Tract Dis 2008;12:63]. J Low Genit Tract Dis 2007;11: 223-239 (Pubitemid 47530910)
14. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Pren-diville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367: 489-498
15. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008; 337:a1284.
16. Sasieni P, Castanon A, Cuzick J. Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data [published erratum appears in BMJ 2009;339:b3115]. BMJ 2009;339:b2968.
17. Howard M, Agarwal G, Lytwyn A. Accuracy of self-reports of Pap and mammography screening compared to medical record: a meta-analysis. Cancer Causes Control 2009;20:1-13.
18. Rauscher GH, Johnson TP, Cho YI, Walk JA. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2008;17:748-757
19. Blake DR, Weber BM, Fletcher KE. Adolescent and young adult women's misunderstanding of the term Pap smear. Arch Pediatr Adolesc Med 2004;158:966-970
20. Saint M, Gildengorin G, Sawaya GF. Current cervical neopla-sia screening practices of obstetrician/gynecologists in the US. Am J Obstet Gynecol 2005;192:414-421
21. Murphy PA, Schwarz EB, Dyer JM. Cervical cancer screening practices of certified nurse-midwives in the United States. J Midwifery Womens Health 2008;53:11-18
22. Castrucci BC, Echegollen Guzmán A, Saraiya M, Smith BR, Lewis KL, Coughlin SS, et al. Cervical cancer screening among women who gave birth in the US-Mexico border region, 2005: the Brownsville-Matamoros Sister City Project for Women's Health. Prev Chronic Dis 2008;5:A116.
23. Stewart FH, Harper CC, Ellertson CE, Grimes DA, Sawaya GF, Trussell J. Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence. JAMA 2001;285:2232-2239
24. Nygärd M, Daltveit AK, Thoresen SO, Nygärd JF. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Serv Res 2007;7:10.
25. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-24.
26. Castle P, Solomon D, Saslow D, Schiffman M. Predicting the effect of successful human papillomavirus vaccination on existing cervical cancer prevention programs in the United States. Cancer 2008;113:3031-3035
27. Goldhaber-Fiebert JD, Stout NK, Ortendahl J, Kuntz KM, Goldie SJ, Salomon JA. Modeling human pa-pillomavirus and cervical cancer in the United States for analyses of screening and vaccination. Popul Health Metr 2007;5:11.
28. Kulasingam SL, Myers ER. Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 2003;290:781-789